Reprogrammed skin cells shed light on HIV-related cognitive impairment

Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...
Fierce Biotech

Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

HIV funding still falls short of targets after pledges: What's at stake

The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...

To knock down health-system hurdles between you and HIV prevention, try these 6 things

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
MercoPress

Brazil's health watchdog gives nod to HIV vaccine

Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...